-SEC Filing
Keybanc Maintains Overweight on i3 Verticals, Lowers Price Target to $30
Keybanc analyst Josh Beck maintains i3 Verticals (NASDAQ:IIIV) with a Overweight and lowers the price target from $40 to $30.
Related Posts
Why Bio-Path Holdings Shares Are Surging Higher Today
Bio-Path Holdings Inc (NASDAQ: BPTH) is surging higher Tuesday after the company announced the U.S Food and Drug Administration reviewed and cleared its Investigational New Drug application for BP1002 in refractory/relapsed acute myeloid leukemia patients.
What’s Going On With Ocugen’s Stock?
Ocugen, Inc. (NASDAQ: OCGN) shares are trading higher amid heightened interest in the stock from retail traders on social media.